BEACON2: expanding treatment options for relapsed neuroblastoma
This recorded session from Solving Kids’ Cancer UK’s 2026 Neuroblastoma Parent Symposium explores the BEACON2 clinical trial for relapsed neuroblastoma, including what the trial is investigating, potential side effects, and future treatment arms. The session also highlights the role of parent advocacy and lived experience in shaping clinical research and trial development.
Related videos
-
VideoIf treatment doesn't go to plan
Explores care for relapsed and refractory neuroblastoma, alongside reflections on hope from a childhood cancer advocate.
-
VideoBambino Gesù CAR T-cell trial
Explore the Bambino Gesù CAR T-cell trial in Rome and its expansion across Europe.
-
VideoTreating relapsed and refractory disease
An overview of clinical trials and new treatments for relapsed and refractory neuroblastoma.